Expert.ai Unveils AI-Powered Solutions for Pharmaceutical and Life Sciences Industries

Expert.ai has announced the debut of its new AI-powered offerings at BioTechX Europe 2025, designed to accelerate innovation across the pharmaceutical, healthcare, and life sciences industries. The company's new solutions empower organizations to enhance data analysis, streamline discovery processes, and unlock new possibilities for clinical trials and therapeutic improvement. The innovative solutions, launched at Europe's largest congress dedicated to pharma & healthcare, will help reduce manual effort, scale insights from massive volumes of data, and ensure regulatory accuracy.

Key Takeaways:

• Expert.ai has launched three new AI-powered solutions: EIX-Submission Readiness, EIX-Preclinical Document Intelligence, and EIX-Clinical Trials Intelligence, aimed at accelerating clinical trials and therapeutic improvement.
• EIX-Submission Readiness empowers teams to build smarter, more efficient workflows for regulatory documentation, reducing manual effort and ensuring regulatory accuracy.
• EIX-Preclinical Document Intelligence streamlines preclinical documentation with greater speed and accuracy, freeing experts to focus on innovation.
• EIX-Clinical Trials Intelligence helps research teams distill the most accurate, up-to-date information by disambiguating across mountains of content from clinical registries, scientific publications, and real-world data.
• EIX-IP Detection delivers comprehensive, explainable insights across patents, scientific literature, and clinical trial data.
• Expert.ai's Hybrid AI approach combines natural language understanding, knowledge graphs, and machine learning/deep learning techniques to create a responsible, transparent, and sustainable AI system.
• The company's new solutions are part of the EidenAI Suite, a suite of ready-to-use AI solutions tailored for vertical markets, including pharmaceuticals and life sciences.

Statistics:

• 30 years of pioneering experience in innovation and technological excellence (Source: Expert.ai website)
• Hundreds of successful projects implemented worldwide (Source: Expert ai website)
• Fortune 1000 clients served around the world (Source: Expert.ai website)
• Expert.ai listed on the Euronext Growth Milan market (EXAI:IM) (Source: Expert.ai website)

Sources:

• Expert.ai website (about.expeai.com)
• Expert.ai press release (prnewswire.com/news-releases/expert-ai-unveils-new-ai-powered-solutions-for-pharmaceutical-and-life-sciences-industries-at-biotex-europe-2025-301367453.html)